MorphoSys AG
MORNASDAQHealthcare
$18.96
+$0.45(+2.43%)
Market Cap$2.9B
P/E Ratio—
52W High$19.5
52W Low$4.185
MorphoSys AG（MOR）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MOR · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.19B) | ($0.15B) | ($0.51B) | $0.10B | ($0.10B) |
| Depreciation & Amort. | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.03B | $0.00B | $0.00B | $0.01B | $0.01B |
| Change in Working Capital | $0.01B | ($0.05B) | ($0.11B) | $0.01B | $0.02B |
| Net Cash from Operations | ($0.30B) | ($0.37B) | ($0.48B) | $0.04B | ($0.08B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.02B) | ($0.03B) | ($0.05B) | ($0.00B) |
| Purchases of Investments | ($3.15B) | ($1.88B) | ($2.19B) | ($1.75B) | ($0.29B) |
| Sales of Investments | $3.15B | $2.24B | $2.59B | $0.92B | $0.37B |
| Net Cash from Investing | $0.02B | $0.35B | ($0.83B) | ($0.88B) | $0.08B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.04B | $0.31B | $1.32B | $0.91B | $0.00B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.30B) | ($0.38B) | ($0.51B) | ($0.01B) | ($0.08B) |
| FCF Margin %(computed) | -125.36% | -137.25% | -282.63% | -4.29% | -116.79% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · EUR · B
深入了解MorphoSys AG
关于MorphoSys AG（MOR）现金流量表
MorphoSys AG 2023财年经营活动现金流($0.30B)，自由现金流($0.30B)（FCF利润率-125.36%），资本支出($0.00B)。
常见问题
MOR · 4 问MorphoSys AG 2023财年自由现金流($0.30B)，同比up21.8%。
MOR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10